Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Organon & Co OGN

Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NYSE:OGN)

Organon Reports Results for the Third Quarter Ended September 30, 2025

Business Wire 4 days ago

New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities

Business Wire 6 days ago

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

PR Newswire 6 days ago

Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie

Business Wire 7 days ago

Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025

Business Wire 8 days ago

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

Business Wire October 28, 2025

Organon Investor Alert: CEO Resigns Amid Audit Probe - Securities Fraud Investigation on Behalf of Organon Investors - Contact Kehoe Law Firm, P.C. - OGN

ACCESS Newswire October 28, 2025

Organon & Co. (OGN) Faces Investor Scrutiny Amid Improper Wholesale Sales Practices, Abrupt CEO Departure -- Hagens Berman

GlobeNewswire October 27, 2025

Kaplan Fox is Investigating Organon & Co. (OGN) Following an Announcement of Findings of an Audit Committee Investigation and CEO Resignation

TheNewsWire October 27, 2025

Opinion & Analysis (NYSE:OGN)

No current opinion is available.

Bullboard Posts (NYSE:OGN)

Sell buddy sell.

Otherwise LOSO for shareholders today
coolfooldumbguy - October 27, 2025

New discovery within Orogen royalty area

New vein system discovered contains huge amounts of gold and silver per ton - Earth.com
forwardflash - August 9, 2025

Question from long term OGN shareholder

Long term OGN small investor here. Topped up my new OGN shares at 1.60 last week, and today a nice pop :-). I want to use some of the...
mmoital - July 21, 2025

RE:Share deal

Checked today and not yet (UK based)
mmoital - July 16, 2025

Share deal

Did anybody not get the shares and cash from the deal with ogn?  I havent received anything yet and my ogn share went to zero.
teejj - July 16, 2025

Merger arbitrage in place

Watched Rick Rule explain this again and he stated a merger arbitrage is in place between tpfm and oregon and that the new oregon spinoff...
fabdaq2021 - July 5, 2025